RHAPSIDO

REMIBRUTINIB · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RHAPSIDO, covering 2025-09-30 to 2025-09-30. Get the full timeline:

Most recent: FDA Approved: RHAPSIDO — Original Application (Novartis Pharmaceuticals Corporation)